Clinical Trial Update: AG Combined With Cadonilimab Sequential Short-course Radiotherapy in the Treatment of Locally aPDAC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating AG in combination with Cadonilimab and sequential short-course radiotherapy for locally advanced pancreatic ductal adenocarcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• AG
• Cadonilimab

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Locally Advanced Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: RECRUITING